Facebook
X
LinkedIn
ForwardRadiation Therapy for Nonmalignant Conditions: Challenges and Updates
This educational series explores the evolving role of radiation therapy in managing nonmalignant conditions, addressing current challenges, emerging evidence, and specialized applications in clinical practice.
TOPICS COVERED
- Pearls and Pitfalls in Nonmalignant Radiation Therapy: Challenging Case Presentations
- Updates on Low Dose Radiotherapy for Osteoarthritis
- Low Dose Radiotherapy (LDRT): Is There an Emerging Role in the Central Nervous System?
Please see the Program tab for the session descriptions and presenters.
This activity is available from September 15, 2025 through 11:59 pm Eastern time on September 14, 2027.
Target Audience
This activity is designed to meet the interests of radiation oncologists, medical oncologists, nurses, pathologists, diagnostic radiologists, physicists, dosimetrists, radiation biologists, radiation therapists, neurologists, residents and allied healthcare professionals interested in radiation therapy for nonmalignant conditions.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Understand technical considerations and outcome optimization in nonmalignant condition management.
- Gain insight into the practice-changing developments for nonmalignant condition management and be aware of future directions.
- Learn about the specialized application of radiation therapy for neurological and psychiatric conditions as well as neurodegenerative diseases.
Pearls and Pitfalls in Nonmalignant Radiation Therapy: Challenging Case Presentations
October 15, 2025 - 12:00 p.m - 1:00 p.m. ET
- M. Heinrich Seegenschmiedt, MD, PhD
- Richard Shaffer, MBBS, MD
- Moderator: Bobby Koneru, MD, FASTRO
Through a series of complex clinical scenarios, this webinar will examine decision-making strategies, technical considerations, and outcome optimization in nonmalignant condition management. Expert faculty will present challenging cases highlighting best practices, common complications, and lessons learned from difficult clinical situations.
Updates on Low Dose Radiotherapy for Osteoarthritis
October 21, 2025 - 1:00 p.m. - 2:00 p.m. ET
- Austin Dove, MD
- Moderator: Bobby Koneru, MD, FASTRO
This webinar will focus on reviewing the most recent literature that has been published on the use of low dose radiation for osteoarthritis. The discussion will highlight the most recently presented and published studies including multiple prospective clinical trials. As evidence continues to strengthen for the use of low dose radiation, this discussion will highlight the most important studies and techniques used for modern low dose radiation.
Low Dose Radiotherapy (LDRT): Is There an Emerging Role in the Central Nervous System?
October 22, 2025 - 1:00 p.m. - 2:00 p.m. ET
- Evan Thomas, MD, PhD
- Moderator: Bobby Koneru, MD, FASTRO
Given the emerging potential of low-dose radiotherapy (LDRT) for managing neuroinflammation in CNS disorders like Alzheimer's disease, clinicians and researchers need to stay informed about its mechanisms, safety, and efficacy. This webinar will provide participants with the latest evidence and insights to bridge the knowledge gap and guide the integration of LDRT into clinical and research settings.
- Nagendra (Bobby) Koneru, MD, FASTRO, is employed by Loyola University Chicago and has no relevant financial relationships with ineligible companies to disclose.
- M. Heinrich Seegenschmiedt, MD, PhD, is employed by ergea MVZ Radiation Therapy Aalen. Dr. Seegenschmiedt receives honoraria as an Advisory Board member, consultant and education/meeting faculty from Varian Medical Systems; honoraria and travel expenses as a consultant and education/meeting faculty from RT-ABC Ltd. Dr. Seegenschmiedt is a Board Member of the International Dupuytren Society and serves as Clinical Chair of the International Organisation of Radiotherapy for Benign Conditions (IORBC).
- Richard Shaffer, MBBS, MD, is employed by RT-ABC Ltd. and Theralife Clinics. Dr. Shaffer receives compensation/payment as a consultant from Dermacure RT LLC and Xstrahl Ltd. Dr. Shaffer has ownership equity in RT-ABC Ltd., Xstrahl Ltd., and Theralife Clinics Ltd. Dr. Shaffer serves as President of the International Organisation of Radiotherapy for Benign Conditions (IORBC).
- Austin Dove, MD, is employed by Tennessee Oncology. Dr. Dove receives compensation/payment and travel expenses as a consultant from Varian Medical Systems.
- Evan Thomas, MD, PhD, is employed by Renaissance Institute of Precision Oncology and Radiosurgery. Dr. Thomas receives research funding (institution) as an Advisory Board member and consultant from Varian Medical Systems.
The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 3.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.00 Certificate of AttendanceThis activity was designated for 3.00 AMA PRA Category 1 Credit™.
Price
Course fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
Member: $199
Member-in-training: $99
Member Student/Grad Student/PGY: $99
Member Postdoctoral Fellow: $99
Nonmember: $299
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until September 14, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.